AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference
AbbVie (NYSE: ABBV) will present at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025. Management will take part in a fireside chat at 7:30 a.m. Central time. A live audio webcast will be available via AbbVie's investor relations site, and an archived recording will be posted later the same day.
AbbVie (NYSE: ABBV) parteciperà alla 37ª Conferenza Annuale di Healthcare di Piper Sandler il mercoledì 3 dicembre 2025. Il management parteciperà a un colloquio informale alle 7:30 del mattino, ora centrale. Una trasmissione audio in diretta sarà disponibile sul sito delle relazioni con gli investitori di AbbVie, e una registrazione archiviata sarà pubblicata più tardi nella stessa giornata.
AbbVie (NYSE: ABBV) participará en la 37.ª Conferencia Anual de Salud de Piper Sandler el miércoles 3 de diciembre de 2025. El equipo directivo participará en una charla informal a las 7:30 a.m. hora central. Se contará con una transmisión en directo por audio a través del sitio de relaciones con inversores de AbbVie, y esa misma jornada se publicará una grabación archivada.
AbbVie (NYSE: ABBV)는 Piper Sandler 37th Annual Healthcare Conference에서 발표할 예정이며, 2025년 12월 3일 수요일에 개최됩니다. 경영진은 중부 표준시 7:30 a.m.의 파이어사이드 채팅에 참여합니다. AbbVie의 투자자 관계 사이트를 통해 라이브 오디오 생중계가 제공되며, 같은 날 나중에 녹화본이 게시됩니다.
AbbVie (NYSE: ABBV) participera à la 37e conférence annuelle sur les soins de santé de Piper Sandler le mercredi 3 décembre 2025. La direction participera à une discussion informelle au coin du feu à 7h30, heure centrale. Une retransmission audio en direct sera disponible via le site des relations investisseurs d'AbbVie, et un enregistrement sera publié plus tard dans la journée.
AbbVie (NYSE: ABBV) wird auf der Piper Sandler 37th Annual Healthcare Conference am Mittwoch, dem 3. Dezember 2025 auftreten. Die Geschäftsführung wird an einem Fireside Chat teilnehmen um 7:30 Uhr Central Time. Ein Live-Audio-Webcast wird über die Investor-Relations-Seite von AbbVie verfügbar sein, und eine aufgezeichnete Version wird im Laufe desselben Tages veröffentlicht.
AbbVie (NYSE: ABBV) ستقدم في المؤتمر الطبي السنوي السابع والثلاثين لشركة بايبر ساندلر في الأربعاء 3 ديسمبر 2025. سيشارك المديرون في حوار بجلسة fireside عند 7:30 صباحاً بتوقيت الوسط. سيتم توفير بث صوتي مباشر عبر موقع علاقات المستثمرين لدى AbbVie، وسيتم نشر تسجيل أرشيف لاحقاً في اليوم نفسه.
- None.
- None.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: Gabby Tarbert | Investors: Liz Shea |
(224) 244-0111 | (847) 935-2211 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-piper-sandler-37th-annual-healthcare-conference-302623535.html
SOURCE AbbVie
